MedCity News May 11, 2021
Anuja Vaidya

Mayo Clinic is ramping up activity in the remote patient monitoring arena. Its latest move is a collaboration with biomedical technology company NXgenPort, which will focus on an implantable catheter that can remotely monitor cancer patients for complications as they undergo treatment.

Just a month after Mayo Clinic announced the launch of Lucem Health — a joint venture that collects and normalizes data from remote devices — the health system is making another move in the remote patient monitoring arena.

On Tuesday, the Rochester, Minnesota-based health system said it is collaborating with a biomedical technology company to support the development of a cancer-focused remote patient monitoring tool.

The company is NXgenPort, headquartered in Minneapolis and Ventura, California. The company’s medical...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Health System / Hospital, Medical Devices, Provider, Technology
STAT+: Another hospital sues MultiPlan, alleging scheme to ‘suppress’ payments
Integrating Mental and Physical Health to Better Support Patients and Communities
Royal Papworth CIO presents six actions for trusts’ AI journey
Opinion: Solving academic medical centers’ existential crisis
Hospitals Are Using AI To Help Manage Patient Messages to Physicians

Share This Article